South Korea’s DongKook Pharmaceutical acquires ReBom Cosmetics, a company specializing in cosmetics R&D and exports. DongKook will purchase 96,600 shares of ReBom Cosmetics for 30.6 billion KRW (US$23 million), netting a 53.6% stake. This move is part of the company’s strategy to diversify its business. DongKook Pharmaceutical CEO Jun-ho Song expects synergies from the deal: “DongKook’s expertise in natural extract technology and herbal medicine development merges with ReBom Cosmetics’ research and manufacturing know-how.”
